|
Burlington stem cell transplant recipient hosting Friday’s Share a Cell fundraiser
Brampton Guardian Tina Ceroni had competed in marathons and triathlons, but facing a rare neuromuscular disease was a whole new challenge. “It was rapidly progressing,” she recalled. “In the summer of 2010, I was in hospital emergency rooms multiple times.” But a stem … Stem cell transplants may dampen sex lifeHealth24.com Stem Cell Transplants May Harm Recipient’s Sex LifeNewsday |
Epratuzumab's Mechanism of Action Featured in Blood, Official Journal of The … – HispanicBusiness.com
|
Epratuzumab’s Mechanism of Action Featured in Blood, Official Journal of The …
HispanicBusiness.com Accompanying the article was an invited commentary by Dr. Ronald P. Taylor of the University of Virginia School of Medicine , who is a pioneer on studies of trogocytosis involving anti-B-cell antibodies, such as rituximab. In the article by Rossi and … |
Epratuzumab's Mechanism of Action Featured in Blood, Official Journal of The … – MarketWatch
|
Epratuzumab’s Mechanism of Action Featured in Blood, Official Journal of The …
MarketWatch Accompanying the article was an invited commentary by Dr. Ronald P. Taylor of the University of Virginia School of Medicine, who is a pioneer on studies of trogocytosis involving anti-B-cell antibodies, such as rituximab. In the article by Rossi and … |
ABBVIE INC : AbbVie Reports Third-Quarter 2013 Financial Results – 4-traders (press release)
ABBVIE INC : AbbVie Reports Third-Quarter 2013 Financial Results4-traders (press release)With partner Biogen Idec, AbbVie presented data from sub-analyses of the Phase 2 SELECT and SELECTION studies evaluating daclizumab. Daclizumab High-Yield Process …
AbbVie Reports Third-Quarter 2013 Financial Results – Wall Street Journal
AbbVie Reports Third-Quarter 2013 Financial ResultsWall Street JournalWith partner Biogen Idec, AbbVie presented data from sub-analyses of the Phase 2 SELECT and SELECTION studies evaluating daclizumab. Daclizumab High-Yield Process (DAC HYP) is being …
‘High-risk’ organs from deceased donors safe when screened with current methods – Science Daily
‘High-risk’ organs from deceased donors safe when screened with current methods Science Daily
A study has shown that after a median of 2.4 years of follow up, 86.5% of transplants of donor kidneys considered “high-risk” for infection and disease were …
AbbVie Reports Third-Quarter 2013 Financial Results – PR Newswire (press release)
AbbVie Reports Third-Quarter 2013 Financial ResultsPR Newswire (press release)With partner Biogen Idec, AbbVie presented data from sub-analyses of the Phase 2 SELECT and SELECTION studies evaluating daclizumab. Daclizumab High-Yield Process (DAC HYP) i…
AbbVie Reports Third-Quarter 2013 Financial Results – MarketWatch
AbbVie Reports Third-Quarter 2013 Financial ResultsMarketWatchWith partner Biogen Idec, AbbVie presented data from sub-analyses of the Phase 2 SELECT and SELECTION studies evaluating daclizumab. Daclizumab High-Yield Process (DAC HYP) is being develope…
Research brings hope of new treatment for asthma patients resistant to … – News-Medical.net
Research brings hope of new treatment for asthma patients resistant to …News-Medical.netNew research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communic…
Bangalore: Street plays that have a message for the heart – Daily News & Analysis
|
Bangalore: Street plays that have a message for the heart
Daily News & Analysis Says Dr CN Manjunath, director, Sri Jayadeva Institute of Cardiovascular Sciences and Research: “It is not just that heart diseases are on the rise among women. The fact that it is considered more of a men’s disease is making a large section of our … |